Csenge Advisory Group’s Natus Medical Inc NTUS Stock Holding History

Csenge Advisory Group’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10	Closed	–	–	1651
2018 Q3	$0	Buy	+10	New	+$353	﹤0.01%	1764

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Csenge Advisory Group's NTUS Position: Q4 2018 in Review

Csenge Advisory Group sold out of Natus Medical Inc (NTUS) in Q4 2018, closing a stake of 10 shares.

Csenge Advisory Group first reported a position in NTUS in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 174 funds tracked by Wall St. Rank hold NTUS as of Q4 2018.

Csenge Advisory Group reported no remaining Natus Medical Inc position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 10 Natus Medical Inc shares in Q4 2018.
Csenge Advisory Group first reported a position in Natus Medical Inc in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Natus Medical Inc position peaked at $0 in Q3 2018.
174 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.